BKYI BIO-key International, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
BKYI Stock | Fundamental Analysis & Investment Insights
NASDAQ
Industrials
Security & Protection Services
Current Price
Live
$0.66
Analyst Target
$2.0
+201.5%
Upside
52W High
$1.97
52W Low
$0.51
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 07, 2026
Market cap
$7.19M
P/E
N/A
ROE
-137.7%
Profit margin
-67.3%
Debt/Equity
0.24
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
92%
Analysis Accuracy
BKYI exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile stability, and lacks an Altman Z-Score, raising unquantified distress risk. The company reports severe profitability issues, including a -67.34% profit margin, -137.69% ROE, and negative earnings across all recent quarters, despite a high gross margin of 78.40%. Revenue has declined 27.7% YoY, and earnings surprises have been consistently negative in the last four quarters, with an average miss of -17.33%. The stock trades at a price-to-book of 0.80, but this is misleading given the company’s deep losses and negative equity. Analysts have a target price of $2.00, but with only one analyst covering the stock and no consensus, this is not reliable.
Key Strengths
High gross margin of 78.40% suggests strong cost control on the production side
Debt/Equity ratio of 0.24 indicates conservative leverage relative to peers
Current ratio of 1.26 and quick ratio of 1.01 suggest short-term liquidity is adequate
Recent quarter-over-quarter EPS growth of +25.0% signals potential improvement in earnings trend
One analyst maintains a $2.00 target price, indicating a speculative upside view
Key Risks
Piotroski F-Score of 4/9 indicates weak financial health and operational instability
Negative ROE (-137.69%) and ROA (-29.40%) reflect severe capital inefficiency and losses
Consistently negative earnings and revenue decline of 27.7% YoY signal deteriorating business fundamentals
No Altman Z-Score available, but the financial profile suggests high bankruptcy risk
Analyst coverage is minimal (only 1 analyst), and target price lacks consensus support
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
24
Weak
45
30
25
20
0
AI Verdict
Weak
Key drivers: Negative profitability and declining revenue, Low Piotroski F-Score, No Altman Z-Score (distress risk unquantified), High earnings surprise misses, Lack of analyst consensus
Confidence
90%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- Price-to-Book of 0.80 suggests potential undervaluation on book value
- Low market cap ($0.01B) may attract speculative interest
Watchpoints
- No Graham Number or intrinsic value due to negative earnings and no growth stability
- P/E and PEG ratios are not applicable due to losses
- Price-to-Sales of 1.05 is elevated for a company with negative earnings
Future
30/100
Ref Growth rates
Positives
- Q/Q EPS growth of +25.0% may indicate a turnaround in earnings trend
- Recent improvement in earnings surprise (e.g., +39.5% in Q2 2025)
Watchpoints
- Revenue growth is -27.7% YoY, indicating ongoing business contraction
- Forward P/E of -2.07 confirms continued losses
- No meaningful earnings growth over the past year despite EPS improvement
Past
25/100
Ref Historical trends
Positives
- Historical gross margin of 78.40% has been stable
- Some quarters show significant earnings beat (e.g., +81.2% in Q3 2023)
Watchpoints
- Consistent earnings misses in the last 4 quarters (avg -17.33%)
- Extreme negative surprises (e.g., -540% in Q4 2020)
- Persistent negative ROE and ROA across multiple years
Health
20/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Debt/Equity of 0.24 is low, indicating conservative capital structure
- Current and quick ratios above 1.0 suggest liquidity adequacy
Watchpoints
- Piotroski F-Score of 4/9 is below the threshold for financial stability
- No Altman Z-Score available, but financials suggest high distress risk
- Negative ROE and ROA indicate poor capital utilization and losses
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio
- Dividend strength is 0/100, indicating no dividend policy
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
-2.07
PEG Ratio
N/A
P/B Ratio
0.8
P/S Ratio
1.05
EV/Revenue
1.05
EV/EBITDA
-1.88
Market Cap
$7.19M
Profitability
Profit margins and return metrics
Profit Margin
-67.34%
Operating Margin
-57.57%
Gross Margin
78.4%
ROE
-137.69%
ROA
-29.4%
Growth
Revenue and earnings growth rates
Revenue Growth
-27.7%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.24
Low debt
Current Ratio
1.26
Good
Quick Ratio
1.01
Good
Cash/Share
$0.19
Quarterly Earnings History
EPS performance vs analyst estimates
2025-11-14
$-0.15
-23.8% surprise
2025-08-13
$-0.2
-33.5% surprise
2025-05-15
$-0.15
+39.5% surprise
2025-03-27
$-0.53
-51.4% surprise
Industrials Sector Comparison
Comparing BKYI against 122 companies in the Industrials sector
(6 bullish, 59 neutral, 57 bearish)
Return on Equity (ROE)
-137.69%
This Stock
vs
7.83%
Sector Avg
-1857.8%
(Below Avg)
Profit Margin
-67.34%
This Stock
vs
57.85%
Sector Avg
-216.4%
(Weaker)
Debt to Equity
0.24
This Stock
vs
5.46
Sector Avg
-95.6%
(Less Debt)
Revenue Growth
-27.7%
This Stock
vs
22.8%
Sector Avg
-221.5%
(Slower)
Current Ratio
1.26
This Stock
vs
2.64
Sector Avg
-52.1%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BKYI
BIO-key International, Inc.
|
BEARISH | $7.19M | - | -137.7% | -67.3% | $0.66 | |
|
AIHS
Senmiao Technology Limited
|
BEARISH | $7.02M | - | -135.7% | -115.7% | $1.54 | |
|
ATXG
Addentax Group Corp.
|
BEARISH | $4.46M | - | -17.7% | -88.0% | $0.38 | |
|
AEHL
Antelope Enterprise...
|
BEARISH | $3.07M | - | -% | -17.7% | $1.86 | |
|
ARTW
Art's-Way Manufacturing Co., Inc.
|
BEARISH | $11.6M | 11.2 | 8.1% | 4.5% | $2.24 |
Past News Coverage
Recent headlines mentioning BKYI from our newsroom.
Newest → oldest
No matching news yet.